Ventyx Biosciences, Inc. (VTYX)
NASDAQ: VTYX · Real-Time Price · USD
1.180
-0.020 (-1.67%)
At close: May 14, 2025, 4:00 PM
1.230
+0.050 (4.24%)
After-hours: May 14, 2025, 5:44 PM EDT

Ventyx Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Net Income
-123.99-135.12-192.96-108.43-83.75-28.17
Upgrade
Depreciation & Amortization
1.31.350.940.470.03-
Upgrade
Loss (Gain) From Sale of Assets
0.040.14----
Upgrade
Asset Writedown & Restructuring Costs
--0.29-21.69-
Upgrade
Loss (Gain) From Sale of Investments
-9.07-9.52-9.18-2.23--
Upgrade
Stock-Based Compensation
21.4222.9328.5916.572.730.05
Upgrade
Other Operating Activities
--0.09--16.6321.12
Upgrade
Change in Accounts Payable
-2.26-2.64-0.751.612.440.59
Upgrade
Change in Other Net Operating Assets
3.6-7.926.55-6.771.570.22
Upgrade
Operating Cash Flow
-108.97-130.87-166.52-98.77-38.65-6.2
Upgrade
Capital Expenditures
-0.08-0.24-0.51-0.28-0.26-
Upgrade
Cash Acquisitions
----1.9-
Upgrade
Investment in Securities
-30.77-15.27101.45-74.66-216-
Upgrade
Investing Cash Flow
-30.86-15.51100.94-74.93-214.37-
Upgrade
Long-Term Debt Issued
----0.456.13
Upgrade
Net Debt Issued (Repaid)
----0.456.13
Upgrade
Issuance of Common Stock
-95.5153.33167.77158.880
Upgrade
Financing Cash Flow
25.93122.1253.33167.77323.556.13
Upgrade
Foreign Exchange Rate Adjustments
0.07-0.06-0.01-0.040.01-
Upgrade
Net Cash Flow
-113.82-24.32-12.27-5.9770.55-0.07
Upgrade
Free Cash Flow
-109.05-131.11-167.04-99.05-38.91-6.2
Upgrade
Free Cash Flow Per Share
-1.54-1.92-2.85-1.89-3.03-3.12
Upgrade
Cash Income Tax Paid
-----0
Upgrade
Levered Free Cash Flow
-61.72-78.46-95.04-58.58-33.09-3.77
Upgrade
Unlevered Free Cash Flow
-61.72-78.46-95.04-58.58-33.03-3.55
Upgrade
Change in Net Working Capital
-1.149.72-5.944.64-6.44-0.81
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q